3 research outputs found

    Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial

    No full text

    Implementation Research: Beyond the Traditional Randomized Controlled Trial

    No full text
    corecore